No Routine Cancer Screening Option? New MCED Tests May Help
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.
Stay updated with breaking news from Ancer Saliva Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.
A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.
A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.
Blood-based screening for CRC may be better than no screening at all, but it can't replace colonoscopy as the gold standard, according to two new modeling studies and an expert consensus commentary.
In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.